| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,320 |
2,038 |
$243K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,585 |
1,491 |
$184K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,026 |
1,855 |
$171K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,913 |
1,724 |
$73K |
| S9083 |
Global fee urgent care centers |
705 |
654 |
$73K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
627 |
583 |
$51K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
575 |
527 |
$49K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
306 |
284 |
$35K |
| 87428 |
|
578 |
553 |
$30K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
758 |
661 |
$26K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
300 |
265 |
$7K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
129 |
118 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,007 |
953 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
413 |
212 |
$2K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
71 |
63 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
189 |
179 |
$340.00 |
| 99072 |
|
54 |
44 |
$322.50 |
| 81003 |
|
157 |
149 |
$194.04 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
17 |
14 |
$108.41 |
| 99000 |
|
569 |
463 |
$107.00 |
| 81025 |
|
28 |
26 |
$72.40 |
| 87807 |
|
12 |
12 |
$58.85 |
| 81002 |
|
12 |
12 |
$16.62 |